Navigation Links
Both Patients and Physicians Most Frequently Recall Roche's Boniva Messages and Link Them to the Sally Field Osteoporosis Campaign
Date:9/9/2009

WALTHAM, Mass., Sept. 9 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that patients and physicians most frequently recall Roche's Boniva messages among the ten surveyed osteoporosis brands likely as a result of the Sally Field marketing campaign. Surveyed physicians most commonly recalled that Sally Field promoted the brand or that Boniva is available as a once-monthly dose. Surveyed patients remember specific details of the advertising campaign such as Sally Field playing with grandchildren; 40 percent of patients who have requested a brand request Boniva from their physicians.

"Roche's use of Sally Field as their spokesperson to promote Boniva has been highly effective. Our study shows that Boniva has the highest message appeal among surveyed brand messages, it highlights the top two patient resonance drivers and its promotional materials have high awareness among surveyed patients and physicians," stated Nicole Westphal, Ph.D., analyst and product manager at Decision Resources.

The new report entitled Brand Perceptions in Osteoporosis also finds that both physicians and patients underestimate the promotional volume of Sanofi-Aventis/Procter & Gamble's Actonel. The most heavily promoted brands are Actonel, with 32 percent of promotional spend, and Boniva, with 30 percent of promotional spend. However, surveyed physicians estimate that 37 percent of the promotional materials they have seen in the last month are for Boniva and 15 percent are for Actonel. Surveyed patients estimate that 50 percent of the promotional materials they have seen in the last month are for Boniva and 11 percent were for Actonel.

"Based on our survey results and analysis, Actonel and Boniva's 2008 overall promotional spend was very similar. However, Roche's success, particularly in the direct-to-consumer space, is probably attributed to the Sally Field promotional campaign. While patients and physicians find Actonel's messages appealing, they frequently attribute Actonel's message to Boniva in brand recall tests. These findings suggest that Actonel's messages are resonating with consumers, but that Sanofi-Aventis/Procter & Gamble needs to better differentiate the agent from Boniva in their promotional campaigns," added Dr. Westphal.

About Brand Perception Series

Decision Resources' Brand Perception Series quantitatively analyzes physician and patient brand perception and message resonance. The findings are driven by extensive primary research and offer clients an unbiased, comprehensive, cost-effective solution to understanding the full competitive brand landscape.

About Decision Resources

Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

    Gisselle Morales               Elizabeth Marshall
    Decision Resources             Decision Resources, Inc.
    781-296-2691                   781-296-2563
    gmorales@dresources.com        emarshall@dresources.com


'/>"/>
SOURCE Decision Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hissey Kientz LLP Urges Patients To Heed FDA Warning About Phospho-soda Products
2. Surgical scrub solution: Its good for patients, too
3. SynergEyes, Inc. Expands Launch of New Hybrid Contact Lens Design for Keratoconus Patients
4. Published Study Shows More Patients See Improvement in Overactive Bladder Symptoms With Urgent(R) PC Device Compared to Those Using a Drug
5. Implanet Using IBM Software to Protect Patients in the Event of Medical Device Recalls
6. Patients pretreatment quality of life can predict overall lung cancer survival
7. Increasing Health Center Capacity by 20 Million Patients Could Save More Than $200 Billion Over the Next Decade
8. Video: New Insights Link Low HDL-Cholesterol and Elevated Triglycerides with Coronary Heart Disease and Microvascular Complications in Patients at Goal for LDL-Cholesterol
9. LIVALO(R) Demonstrates Sustained, Long-Term Efficacy and Tolerability in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia
10. FertilityTies, Social Network for the Fertility-Focused Unveils New Site Design, Unique Features to Help Patients Find Fertility Doctors & More
11. New hope for heart failure patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... for healthcare compliance program management, will showcase a range of technology and learning ... Assisted Living (NCAL) Convention and Expo to be held October 14–18, 2017 at ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) ... FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... Morris F. Collen, a pioneer in the field of medical informatics, this prestigious award ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... wound care advancements to physician colleagues, skilled nursing facility medical directors and other ... Treacherous Waters of Wound Care." , "At many of these conferences we get ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
(Date:9/19/2017)... 19, 2017   ZirMed Inc ., a recognized leader ... that it has been ranked #1 by its users for ... Rankings 2017 User Survey. ZirMed was recognized as the top-ranked ... and medical centers over 200 beds and holds one of ... user survey history. ...
Breaking Medicine Technology: